Ontology highlight
ABSTRACT: Objectives
To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.Methods
A prospective, randomized, double-blind method was used to determine the efficacy and safety of the combination or placebo at baseline and 4, 8, and 12 weeks of study. The International Prostate Symptom Score, quality of life index, complete voiding diary, and National Institutes of Health-Chronic Prostatitis Symptom Index were studied. Uroflowmetery and postvoid residual urine volume were measured and compared. Laboratory tests including prostate-specific antigen were performed.Results
In all groups, International Prostate Symptom Score and quality of life showed improvement, but n
SUBMITTER: Lee CL
PROVIDER: S-EPMC9314056 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature